Home › Funds › Artia Global Partners LP › MBX

Artia Global Partners LP position in MBX

MBX BIOSCIENCES INC · Health Care

Artia Global Partners LP reported holding 8,300 shares of MBX (MBX BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$487K, representing 0.10% of its reported portfolio and ranking #48 among its reported holdings. Artia Global Partners LP first reported this position in Q3 2026.

Latest position (Q3 2026)8.30K sh
Reported value held$486.55K
Portfolio Weight0.10%
First reportedQ3 2026
Last changeNew
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Artia Global Partners LP's MBX position evolved

Artia Global Partners LP first disclosed a stake in MBX in Q3 2026 at 8,300 shares (US$487K).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 8.30K $486.55K New

About MBX and 13F data

MBX (MBX BIOSCIENCES INC) is a Health Care company. 62 other funds we track also report a position in MBX — the largest reported positions include Frazier Life Sciences Management, L.P. (US$367.2M), Paradigm Biocapital Advisors LP (US$221.2M), NEA Management Company, LLC (US$199.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MBX

All MBX fund holders →

FAQ

How long has Artia Global Partners LP held MBX?

Artia Global Partners LP has disclosed MBX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Artia Global Partners LP's current position in MBX?

As of Q3 2026, Artia Global Partners LP holds 8.30K shares of MBX (MBX BIOSCIENCES INC), valued at $486.55K, representing 0.10% of its reported portfolio and ranking #48.

Has Artia Global Partners LP been buying or selling MBX?

In the latest 13F filing (Q3 2026), Artia Global Partners LP newly opened its position in MBX.

Which other funds hold MBX?

Other major institutional holders of MBX include Frazier Life Sciences Management, L.P., Paradigm Biocapital Advisors LP, NEA Management Company, LLC, among 62 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.